Market Overview

The key factors propelling the whole slide imaging market are their increasing use in drug discovery processes, technological advancements in whole slide imaging, and growing popularity of virtual slides as compared to physical slides. Also, the increasing incidence of cancer is expected drive the growth of the overall market.

With the growing research, there are many pharmaceutical and biotech companies that have made significant investments in drug discovery. As a consequence, imaging is now performed in all drug discovery processes. Therefore, imaging and image-based technologies are now commonplace across the drug discovery workflow and they hold great promise for R&D, allowing researchers to understand and work with model organisms. Thus, it is expected to improve standardization, quality, and manageability of research, and help reduce costs. Thus, as research in drug discovery grows, it is expected to directly impact the growth of whole slide imaging market.

Digital pathology (DP) is also a rapidly growing field that has generated a lot of interest among hospitals, laboratories, surgeons, research institutes, and healthcare companies, among others. The digital pathology process is expected to significantly increase, and thereby, increase productivity and efficiency by allowing pathologists to stay in their offices rather than travel to numerous locations.

With the advancement of digital pathology and computer-assisted artificial intelligence technology, it is inevitable that digital health will come to play an important role in the strategic planning of cancer research and precision medicine delivery.

Thus, whole slide imaging devices are increasingly being used for cancer research and precision medicine, as many disease can be defined by being examined under the microscope. Pathologists' involvement in precision medicine and digital technology will be a key driver for improving patient care. As a result, this is a great opportunity for the growth of the market.

Scope of the Report

As per the scope of the report, whole slide imaging involves physical slides, which are transformed into digital resources that can be analyzed on any computer, easily stored, and quickly shared with colleagues wherever they are. It refers to the scanning of conventional glass slides in order to produce digital slides, and it is the most recent imaging modality being employed by pathology departments,worldwide.

• MARKET SEGMENTATION
  • By Technology
    • Scanners
    • IT Infrastructure
    • Viewer
    • Image Management System
  • By Application
    • Telepathology
    • Cytopathology
    • Immunohistochemistry
    • Hematopathology
  • By End-user
    • Education
    • Research
    • Clinical
  • Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South korea
      • Rest of Asia-Pacific
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Key Market Trends

Immunohistochemistry Application Segment is Expected to Grow the Fastest During the Forecast Period

Immunohistochemistry (IHC) is a method for detecting antigens or haptens in the cells of a tissue section, by using the principle of antibodies binding specifically to antigens in biological tissues. It is a widely used technique in pathology to observe protein expression in tissue samples. It is also gaining importance as many biotech companies use immunohistochemistry in early research and later stage drug development. Thus, with more advanced processes, this method helps in faster assessment of samples.

There has also been increased use of whole slide imaging to study blood coagulation disorders to hematopoietic neoplasms. Although there has been increased interest by pharmaceutical companies to use WSI products to develop biomarkers, the acceptance of digitized images in clinical validation studies by regulatory authorities still remains a challenge.